Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma

Lung Cancer

Volumn 66, Issue 2, 2009, Pages 237-244

  Wang, Rui ^a   Geng, Jian ^a   Wang, Jing hua ^a   Chu, Xiao yuan ^a   Geng, Huai cheng ^a   Chen, Long bang ^a  

^a NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

Author keywords

Eukaryotic initiation factor 4E (eIF4E); Immunohistostaining; Lung adenocarcinoma; p53; Prognosis

Indexed keywords

INITIATION FACTOR 4E; MESSENGER RNA; PROTEIN P53; TELOMERASE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING HABIT; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

ADENOCARCINOMA; CELL LINE, TUMOR; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 69949189840     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.02.001     Document Type: Article

References (28)

1. Little A.G., Gay E.G., Gaspar L.E., and Stewart A.K. National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer 57 (2007) 253-260
2. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
3. Martini B. Lung cancer-epidemiology, prognosis and therapy. Med Monatsschr Pharm 29 (2006) 217-221
4. Hunt P. Diagnosing and managing patients with lung cancer. Nurs Stand 22 (2008) 50-56
5. Von Der, Haar T., Ball P.D., and McCarthy J.E. Stabilization of eukaryotic initiation factor 4E binding to the mRNA 5′-Cap by domains of elF4G. J Biol Chem 275 (2000) 30551-30555
6. Joshi B., Cameron A., and Jagus R. Characterization of mammalian eIF4E-family members. Eur J Biochem 271 (2004) 2189-2203
7. Byrnes K., White S., Chu Q., Meschonat C., Yu H., Johnson L.W., et al. High eIF4E, VEGF, and microvessel density in stage I to III breast cancer. Ann Surg 243 (2006) 684-690
8. Nathan C.A., Carter P., Liu L., Li B.D., Abreo F., Tudor A., et al. Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas. Oncogene 15 (1997) 1087-1094
9. Rousseau D., Kaspar R., Rosenwald I., Gehrke L., and Sonenberg N. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc Natl Acad Sci USA 93 (1996) 1065-1070
10. Ruggero D., Montanaro L., Ma L., Xu W., Londei P., Cordon-Cardo C., et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med 10 (2004) 484-486
11. Nathan C.O., Liu L., Li B.D., Abreo F.W., Nandy I., and De Benedetti A. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer. Oncogene 15 (1997) 579-584
12. Rosenwald I.B., Chen J.J., Wang S., Savas L., London I.M., and Pullman J. Upregulation of protein synthesis initiation factor eIF4E is an early event during colon carcinogenesis. Oncogene 18 (1999) 2507-2517
13. Wang S., Rosenwald I.B., Hutzler M.J., Pihan G.A., Savas L., Chen J.J., et al. Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. Am J Pathol 155 (1999) 247-255
14. Lee J.W., Choi J.J., Lee K.M., Choi C.H., Kim T.J., Lee J.H., et al. eIF-4E expression is associated with histopathologic grades in cervical neoplasia. Hum Pathol 36 (2005) 1197-1203
15. Fields A.C., Cotsonis G., Sexton D., Santoianni R., and Cohen C. Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome. Mod Pathol 17 (2004) 1378-1385
16. Shijubo N., Uede T., Kon S., Maeda M., Segawa T., Imada A., et al. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma. Am J Respir Crit Care Med 160 (1999) 1269-1273
17. Novaes F.T., Cataneo D.C., Ruiz Junior R.L., Defaveri J., Michelin O.C., and Cataneo A.J. Lung cancer: histology, staging, treatment and survival. J Bras Pneumol 34 (2008) 595-600
18. Nakamura N., Kobayashi K., Nakamoto M., Kohno T., Sasaki H., Matsuno Y., et al. Identification of tumor markers and differentiation markers for molecular diagnosis of lung adenocarcinoma. Oncogene 25 (2006) 4245-4255
19. De Benedetti A., and Graff J.R. eIF-4E expression and its role in malignancies and metastases. Oncogene 23 (2004) 3189-3199
20. De Benedetti A., and Harris A. eIF4E expression in tumors: its possible role in progression of malignancies. Int J Biochem Cell Biol 31 (1999) 59-72
21. Clemens M.J. Targets and mechanisms for the regulation of translation in malignant transformation. Oncogene 23 (2004) 3180-3188
22. Wendel H.G., Silva R.L., Malina A., Mills J.R., Zhu H., Ueda T., et al. Dissecting eIF4E action in tumorigenesis. Genes Dev 21 (2007) 3232-3237
23. Li B.D., Liu L., Dawson M., and De Benedetti A. Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma. Cancer 79 (1997) 2385-2389
24. Sorrells Jr. D.L., Ghali G.E., De Benedetti A., Nathan C.A., and Li B.D. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers. J Oral Maxillofac Surg 57 (1999) 294-299
25. Dong K, Wang R, Wang X, Lin F, Shen JJ, Gao P, et al. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Breast Cancer Res Treat; 2008 March 10 [Epub ahead of print].
26. Walsh D., Meleady P., Power B., Morley S.J., and Clynes M. Increased levels of the translation initiation factor eIF4E in differentiating epithelial lung tumor cell lines. Differentiation 71 (2003) 126-134
27. Cheah P.L., and Looi L.M. p53: an overview of over two decades of study. Malay J Pathol 23 (2001) 9-16
28. Nathan C.O., Sanders K., Abreo F.W., Nassar R., and Glass J. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications. Cancer Res 60 (2000) 3599-3604